Introduction {#sec1-1}
============

Research area of human gut microbiota has been booming since gut bacteria are closely related to human physiology including immunity, obesity, diabetes, metabolic syndrome, brain health, and so on ([@ref2]; [@ref24]; [@ref27]; [@ref29]). In particular, human gut bacterial composition is one of the most important factors for maintaining intestinal homeostasis ([@ref30]). Balance between beneficial bacteria and harmful ones should be considered when measuring the health status of individual gut. Bifidobacteria and lactic acid bacteria (LAB) are among the most beneficial bacteria in our gut ([@ref18]). Bifidobacteria are normally living in the colon. They produce not only lactic acid, but also acetic acid which shows strong antimicrobial activity against pathogenic bacteria ([@ref11]; [@ref28]). These bacteria also possess other beneficial effects such as immunological, anti-diarrheal, anti-constipation, anti-inflammation, and anti-cancer effects ([@ref1]; [@ref8]; [@ref14]; [@ref25]). For these reasons, bifidobacteria are broadly used as probiotics in functional food market ([@ref16]). In particular *Bifidobacterium catenulatum* which belongs to the *B. adolescentis* group has been rarely studied but abundant in feces from humans ([@ref9]; [@ref19]). Therefore *B. catenulatum* was used as a model for genetic recombination.

Molecular imaging is a powerful tool to investigate phenomena in biological nature. It gives researchers direct evidences via visualization ([@ref23]). In general, green fluorescence protein (GFP) and luciferase genes are used for labelling LAB and bifidobacteria. These labelled bacteria have been applied in *in vitro*, *in situ*, and *in vivo* tests to monitor their behaviors ([@ref6]; [@ref12]; [@ref15]; [@ref17]; [@ref20]). The *luxA-luxB* gene cassette of *Vibrio harveyi* and the *gfp* gene of *Aequora victoria* were used for labeling *Lactococcus lactis* strain to investigate its survival, physiology, and lysis in the different compartments of murine digestive tracts ([@ref6]). The strain orally administered with the diet was resistant to gastric juice (90 to 98% survival), whereas 10-30% was survived in the duodenum. A *Lactobacillus plantarum* strain was labeled with a luciferase gene and monitored in a complex food matrix during fermentation ([@ref20]). The strain was successfully detected in the matrix during the fermentation by measuring bioluminescent signals. In a previous paper for *Bifidobacterium* sp., researchers have shown that a niche environment of a *B. breve* strain in murine intestine is the cecum via molecular imaging technique using a luciferase ([@ref5]).

In this study, we developed a novel labelling system for bifidobacteria using a luciferase gene based on a replicon of plasmid pFI2576 previously identified from *B. longum* FI10564 ([@ref21]). The recombinant *B. catenulatum* \[pTG262::pFI2576 rep (*luc^+^*)\] successfully showed a luminescence signal.

Materials and Methods {#sec1-2}
=====================

Bacterial strains and culture conditions {#sec2-1}
----------------------------------------

*Escherichia coli* DH5α and *E. coli* MC1022 were cultured in LB broth (10 g/L NaCl, 10 g/L tryptone, and 5 g/L yeast extract, pH 7.0) at 37°C with shaking. *B. catenulatum* \#27, which was previously isolated from human fecal samples in our lab and identified by 16S rRNA gene sequence analysis, was cultured in MRS (De Man, Rogosa, and Sharpe) broth at 37°C under anaerobic condition (Whitley A95 Anaerobic Workstation, Don Whitley Scientific, Bradford, UK). For antibiotic selection of recombinant strains, 100 μg/mL of ampicillin (Sigma, Poole, UK) was used for *E. coli* while 15 and 5 μg/mL of chloramphenicol (Sigma) were used for *E. coli* and *B. catenulatum*, respectively.

Construction of recombinant DNAs {#sec2-2}
--------------------------------

Plasmids and primers used in this study are listed in [Table 1](#T1){ref-type="table"}. pFI2576 rep (\~2.0 kb) PCR product was produced with pFI2576 rep F-1 and R-1 primer set under the following PCR conditions: initial denaturation at 98°C for 30 s; 30 cycles of 98°C for 10 s and 72°C for 1 min; final extension at 72°C for 5 min. Phusion-HF DNA polymerase (Thermo Scientific, UK) was used for PCR. PCR product was digested with SalI restriction endonuclease (New England Biolabs, Hitchin, UK) and inserted into pUC19 cloning vector digested with the same restriction enzyme. A luciferase gene (*luc^+^*) was liberated with XbaI and EcoRI restriction endonucleases (New England Biolabs) from pLuc2 recombinant plasmid and inserted into pTG262 vector. The cloned pFI2576 rep was digested with SalI enzyme and subcloned into recombinant pTG262 (*luc^+^*) digested with the same enzyme. The final recombinant DNA was named pTG262::pFI2576 rep (*luc^+^*).

###### Plasmids and primers used in this study

  Plasmid or primer                   Description or sequence (5'→ 3')                                                 Reference
  ----------------------------------- -------------------------------------------------------------------------------- ------------
  Plasmid                                                                                                              
     pFI2576                          2.2 kb; A cryptic plasmid isolated from *Bifidobacterium longum* FI10564         [@ref21]
     pUC19                            2.7 kb; *E. coli* cloning vector, Ap^r^                                          [@ref26]
     pUC19::pFI2576 rep               4.7 kb; pFI2576 replicon (\~2.0 kb) PCR product was inserted into pUC19, Ap^r^   This study
     pTG262                           5.6 kb; Shuttle vector, Cm^r^                                                    [@ref10]
     pLuc2                            8.5 kb; Shuttle vector harboring a luciferase gene (*luc^+^*), Ap^r^, Em^r^      [@ref7]
     pTG262 (*luc^+^*)                7.4 kb; *luc^+^* gene was inserted into pTG262, Cm^r^                            This study
     pTG262::pFI2576 rep (*luc^+^*)   9.4 kb; pFI2576 rep was inserted into pTG262 (*luc^+^*), Cm^r^                   This study
  Primer                                                                                                               
     pFI2576 rep F-1                  acgc[gtcgac]{.ul}ggttgttgctccagcacc                                              This study
     pFI2576 rep R-1                  acgc[gtcgac]{.ul}ctccaatcgtccgtcga                                               This study

Ap^r^, resistant to ampicillin, Cm^r^, resistant to chloramphenicol, Em^r^, resistant to erythromycin, SalI sites (-gtcgac-) are underlined in primer sequences.

Transformation of *B. catenulatum* {#sec2-3}
----------------------------------

Transformation method was based on a previously published paper ([@ref3]). For preparation of electro-competent cells, 50 mL of *B. catenulatum* \#27 were cultured in MRS broth supplemented with 0.05% L-cysteine and 0.5 M sucrose. After reaching OD~600~ of 0.31, they were set on ice for 20 min. These cells were washed twice with 45 mL of ice-cold electroporation buffer (0.5 M sucrose in 1 mM HEPES buffer, pH 6.0) and then washed with 1 mL of the same buffer twice. Cells were finally resuspended with 200 μL of the same buffer. Recombinant DNA of pTG262::pFI2576 rep (*luc^+^*) (105 ng) was transferred to 80 μL of electro-competent cells of *B. catenulatum* \#27 under electroporation condition of 2.0 kV, 25 μF, and 200 Ω using GenePulser Xcell (Bio-Rad), recovered with 800 μL of MRS broth supplemented with 0.05% L-Cys and 0.5 M sucrose in an anaerobic cabinet (Whitley A95 Anaerobic Workstation), and selected on MRS agar plate supplemented with 5 μg/mL of chloramphenicol (Sigma).

Measurement of bioluminescence {#sec2-4}
------------------------------

Bioluminescence of recombinant *E. coli* and *B. catenulatum* was measured with a luciferase assay system (E1500; Promega, USA) according to manufacturer's guidance. Cell culture (200 µL) was centrifuged, resuspended with 20 μL of phosphate buffered saline (Sigma), and loaded into a 96-well microplate (Black Costar flat bottom, Corning, USA). Luciferase assay reagent (100 µL) was added to the microplate and bioluminescent signal was measured with a BMG FLUOstar OPTIMA Microplate Reader (BMG LABTECH GmbH, Germany).

Results and Discussion {#sec1-3}
======================

PCR amplification of pFI2576 replicon {#sec2-5}
-------------------------------------

For construction of *E. coli*-*Bifidobacterium* shuttle vector, a *Bifidobacterium* plasmid replicon from pFI2576 was amplified by PCR. pFI2576 rep F-1 and R-1 primer set ([Table 1](#T1){ref-type="table"}) successfully amplified a PCR product with expected size of 2,012 bp ([Fig. 1A](#F1){ref-type="fig"}). Partial nucleotide sequence of the PCR product was 100% identical to original pFI2576 replicon sequence (data not shown), indicating that PCR product was correctly amplified.

![Amplification of pFI2576 replicon (A) and restriction of pUC19::pFI2576 rep (B).\
(A) M: HyperLadder™ 1 kb (Bioline Reagents Ltd., London, UK); 1: PCR amplification of the replicon region of pFI2576 (20 μL reaction); 2: PCR amplification of the replicon region of pFI2576 (50 μL reaction). (B) M: HyperLadder™ 1 kb; 1: pUC19 (SalI); 2: pUC19::pFI2576 rep \#1 (SalI); 3: pUC19::pFI2576 rep \#2 (SalI).](kosfa-38-4-816-g1){#F1}

Construction of recombinant DNAs {#sec2-6}
--------------------------------

The pFI2576 replicon PCR product was inserted into pUC19 cloning vector. The insert (\~2.0 kb) was confirmed by SalI restriction endonuclease digestion ([Fig. 1B](#F1){ref-type="fig"}). The recombinant DNA pTG262 (*luc^+^*) was also confirmed by restriction digestion with EcoRI and XbaI endonuclease where *luc^+^* gene (\~1.8 kb) was liberated ([Fig. 2A](#F2){ref-type="fig"}) from pTG262. pTG262::pFI2576 rep (*luc^+^*) was finally constructed. Its physical genetic map is shown in [Fig. 2B](#F2){ref-type="fig"}.

![Restriction of pTG262 (*luc^+^*) (A) and physical genetic map of pTG262::pFI2576 rep (*luc^+^*) (B).\
M: HyperLadder™ 1 kb (Bioline Reagents Ltd.); 1: pTG262 \[CCC (covalently closed circular) type\]; 2: pTG262 (*luc^+^*) (CCC type); 3: pTG262 (*luc^+^*) (EcoRI-XbaI).](kosfa-38-4-816-g2){#F2}

Bioluminescence of recombinant strains {#sec2-7}
--------------------------------------

As mentioned above, pTG262::pFI2576 rep (*luc^+^*) was successfully constructed for labelling *Bifidobacterium* species. Before transforming *Bifidobacterium* sp., luminescent signal of *E. coli* MC1022 \[pTG262::pFI2576 rep (*luc^+^*)\] was measured. *E. coli* MC1022 \[pTG262::pFI2576 rep (*luc^+^*)\] showed very strong luminescent signal (1.0×10^6^ RLU), whereas *E. coli* MC1022 (pTG262::pUC19::pFI2576 rep) as a negative control showed only basal signal (13 RLU), indicating that the recombinant DNA was properly constructed for bioluminescent labelling. These two recombinant DNAs were transferred to *B. catenulatum* \#27. Transformation efficiencies for pTG262::pUC19::pFI2576 rep and pTG262::pFI2576 rep (*luc^+^*) were 1.3×10^3^ and 4.8×10^1^ CFU/μg DNA, respectively. Colonies (two each) were selected and cultured under anaerobic condition and luminescent signals were measured. As shown in [Fig. 3](#F3){ref-type="fig"}, two cultures for *B. catenulatum* \#27 (pTG262::pUC19::pFI2576 rep) presented luminescent signals of 2 and 4 RLU, whereas *B. catenulatum* \#27 \[pTG262::pFI2576 rep (*luc^+^*)\] presented signals of 3,024 and 1,031 RLU. The difference in luminescent signal between the two cultures of *B. catenulatum* \#27 \[pTG262::pFI2576 rep (*luc^+^*)\] might be due to growth state.

![Bioluminescence of recombinant *Bifidobacterium catenulatum* (Bc) \#27.\
Control: a control vector pTG262::pUC19::pFI2576 rep; Luc: pTG262::pFI2576 rep (*luc^+^*). Each measurement was done in triplicate and means and standard deviations are presented.](kosfa-38-4-816-g3){#F3}

To date, very limited information is available for development of luciferase-based labelling system for bifidobacteria. [@ref4] have introduced *in vivo* bioluminescence imaging technique where *E. coli* and *B. breve* are engineered to express *lux* gene cassette. [@ref22] have used an imaging analyzing method to evaluate *in situ* bioluminescence from a recombinant *B. longum* expressing bacterial luciferase to understand the effect of dissolved oxygen concentration. [@ref13] have applied a bioluminescent labelling tool to study the physiological state of *B. longum* strain under various environmental conditions. As described in these papers, bioluminescent labelling system could be broadly used to understand physiological states and behaviors of strictly anaerobic *Bifidobacterium* sp. in *in vitro*, *in situ*, and *in vivo*. In the present study, we developed a luciferase-based labelling system for bifidobacteria. This system successfully worked in a *B. catenulatum* strain as a model. In the near future, the system could be applied to other *Bifidobacterium* species to investigate their physiology and roles under various environments.
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